-
Mashup Score: 0
Genomic profiling represents the first clinical practice–ready tool for precision oncology in metastatic prostate cancer. Here we outline current testing considerations and gray zones regarding how best to apply genomic testing in the clinic. The lessons we learn today will continue to shape how we integrate evolving biology and future technologies into practice.
Source: European Urology FocusCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Biomarkers are now ubiquitous in prostate cancer care. In addition to longstanding use of prostate-specific antigen, we now have secondary serum-, urine-, and tissue-based markers that help in optimizing patient care and patient compliance with therapeutic recommendations. The ship has sailed: these markers are useful and are here to stay.
Source: European Urology FocusCategories: Hem/Oncs, Latest HeadlinesTweet-
Biomarkers Accurately Inform Treatment Decisions in Localized Prostate Cancer https://t.co/pn6QBv0NhP Here is recent brief review of prostate biomarkers including PHI, EXO Dx, Decipher, Oncotype.
-
-
Mashup Score: 9
Minimal use of hemostatic energy close to the neurovascular bundle has been a “dogma” of the nerve-sparing technique. We demonstrate that dissection of the lateral prostatic pedicle with bipolar energy is oncologically and functionally similar to the standard approach with shorter operative time.
Source: European Urology FocusCategories: Hem/Oncs, Latest HeadlinesTweet-
2-year erectile function recovery rates were 71% vs. 67% for bipolar vs. clips (p=0.65). Clipless Robotic-assisted Radical Prostatectomy and Impact on Outcomes https://t.co/fWNGc5OoeW @SBasourakos @aleczhu @AjhungMD @ash_ramaswamy @eemilycheng @FKhaniPath
-
-
Mashup Score: 11Improving Guideline Adherence in Urology - 3 year(s) ago
There are evidence-practice gaps in urology. Implementation science approaches should be used to improve adherence to clinical practice guidelines. This will require a concerted effort from multiple stakeholders to describe practice variations, understand reasons for nonadherence, and design implementation interventions.
Source: European Urology FocusCategories: Latest Headlines, UrologyTweet-
RT @EurUrolFocus: Improving Guideline Adherence in Urology https://t.co/uyKb3rq8a3 @5tevenMacLennan @veerukasi @kmj_gallagher @GGandaglia…
-
-
Mashup Score: 3Management of Urosymphyseal Fistula and Pelvic Osteomyelitis: A Comprehensive Institutional Experience and Improvements in Pain Control - 4 year(s) ago
Although a rare condition, urosymphyseal fistula commonly presents with severe pain and abscess, but diagnosis may be delayed. Pelvic bone removal with bladder removal or repair can result in lower long-term pain and opioid use.
Source: European Urology FocusCategories: Latest Headlines, UrologyTweet-
RT @UAnele: https://t.co/0n3HGPkIbw Fortunate to have our experience recently published in @EurUrolFocus ! It's a small, humble addition to…
-
-
Mashup Score: 3
Our retrospective multicentre study suggests that conservative management with bacillus Calmette-Guérin (BCG) immunotherapy could achieve satisfactory results among T1 micropapillary bladder cancer patients compared with immediate radical cystectomy, especially among individuals with lymphovascular invasion or pure micropapillary bladder cancer at initial diagnosis.
Source: European Urology FocusCategories: General Medicine News, Latest HeadlinesTweet-
RT @AndreaNecchi: Another great piece from the @EAUYAUrology Chiara Lonati @UroMoschini @urotoday https://t.co/YKtvY4eegd
-
-
Mashup Score: 0
Our retrospective multicentre study suggests that conservative management with bacillus Calmette-Guérin (BCG) immunotherapy could achieve satisfactory results among T1 micropapillary bladder cancer patients compared with immediate radical cystectomy, especially among individuals with lymphovascular invasion or pure micropapillary bladder cancer at initial diagnosis.
Source: European Urology FocusCategories: Hem/Oncs, Latest HeadlinesTweet-
Another great piece from the @EAUYAUrology Chiara Lonati @UroMoschini @urotoday https://t.co/YKtvY4eegd
-
-
Mashup Score: 0Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy - 4 year(s) ago
Correct identification of variant histologies of bladder cancer at transurethral resection of the bladder (TURB) drives the subsequent treatment. Unfortunately, the degree of concordance between TURB specimen and radical cystectomy specimen appears to be slight (76%).
Source: European Urology FocusCategories: Latest Headlines, UrologyTweet-
Important work by @UroMoschini @EAUYAUrology detection of VH with TURBT important for Rx planning and trial inclusion @urotoday @EurUrolFocus https://t.co/hbpUOIyamH
-
-
Mashup Score: 0
We read with great interest the recent report by Soria and colleagues [1] on perioperative outcomes after open radical cystectomy (ORC) and robot-assisted radical cystectomy (RARC). The authors must be commended for the collection of an impressive cohort of bladder cancer (BCa) patients (>1800 individuals) who were treated with either ORC or RARC at 25 European and North American institutions…
Source: European Urology FocusCategories: Hem/Oncs, Latest HeadlinesTweet-
Re: Francesco Soria, Marco Moschini, David D’Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233–9 https://t.co/efSLQwLKFS
-
-
Mashup Score: 0
Patients with advanced genitourinary cancers experience clinically relevant psychosocial distress. Routine psychosocial screening has the ability to identify patients’ unmet needs and assist the health care team in addressing such symptoms. Effective supportive care modalities, including remote home-based interventions, have the potential to mitigate emotional symptom burden and improve disease…
Source: European Urology FocusCategories: Hem/Oncs, Latest HeadlinesTweet-
Humbled and honored to be part of this terrific initiative! Thank you @zklaassen_md for inviting me to write about “Distress and Quality of Life Among Patients with Advanced Genitourinary Cancers” 🤩 https://t.co/7RIfAqkCtu #MentalHealthMatters #GUCancers https://t.co/0RjYhO3iXK
-
Moving Precision Oncology for Advanced Prostate Cancer from Theory to Practice https://t.co/B992Zsvi7Q via @mishabeltran et al https://t.co/GEJaDBufKd